{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:49:05Z","timestamp":1790455745914,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21 CA263262"],"award-info":[{"award-number":["R21 CA263262"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA263986"],"award-info":[{"award-number":["U01 CA263986"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"DOI":"10.13039\/100009863","name":"Neuroendocrine Tumor Research Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100009863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-024-00708-5","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T04:02:03Z","timestamp":1727928123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Proteomic basis for pancreatic acinar cell carcinoma and pancreatoblastoma as similar yet distinct entities"],"prefix":"10.1038","volume":"8","author":[{"given":"Atsushi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7495-2133","authenticated-orcid":false,"given":"Matthew M.","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9458-5825","authenticated-orcid":false,"given":"Julia Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4892-1098","authenticated-orcid":false,"given":"Michael H. A.","family":"Roehrl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"708_CR1","doi-asserted-by":"publisher","first-page":"808","DOI":"10.5858\/arpa.2019-0472-RA","volume":"144","author":"ED Thompson","year":"2020","unstructured":"Thompson, E. D. & Wood, L. D. Pancreatic neoplasms with acinar differentiation: a review of pathologic and molecular features. Arch. Pathol. Lab. Med. 144, 808\u2013815 (2020).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"708_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/00000478-199209000-00001","volume":"16","author":"DS Klimstra","year":"1992","unstructured":"Klimstra, D. S., Heffess, C. S., Oertel, J. E. & Rosai, J. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am. J. Surg. Pathol. 16, 815\u2013837 (1992).","journal-title":"Am. J. Surg. Pathol."},{"key":"708_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canlet.2008.01.026","volume":"264","author":"WZ Gu","year":"2008","unstructured":"Gu, W. Z., Zou, C. C., Zhao, Z. Y., Liang, L. & Tang, H. F. Childhood pancreatoblastoma: clinical features and immunohistochemistry analysis. Cancer Lett. 264, 119\u2013126 (2008).","journal-title":"Cancer Lett."},{"key":"708_CR4","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1158\/2159-8290.CD-14-0617","volume":"4","author":"J Chmielecki","year":"2014","unstructured":"Chmielecki, J. et al. Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes. Cancer Discov. 4, 1398\u20131405 (2014).","journal-title":"Cancer Discov."},{"key":"708_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/path.4310","volume":"232","author":"Y Jiao","year":"2014","unstructured":"Jiao, Y. et al. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J. Pathol. 232, 428\u2013435 (2014).","journal-title":"J. Pathol."},{"key":"708_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep08829","volume":"5","author":"T Furukawa","year":"2015","unstructured":"Furukawa, T. et al. Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas. Sci. Rep. 5, 8829 (2015).","journal-title":"Sci. Rep."},{"key":"708_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0002-9440(10)64917-6","volume":"160","author":"SC Abraham","year":"2002","unstructured":"Abraham, S. C. et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC\/beta-catenin pathway. Am. J. Pathol. 160, 953\u2013962 (2002).","journal-title":"Am. J. Pathol."},{"key":"708_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/MPA.0000000000000190","volume":"43","author":"W Liu","year":"2014","unstructured":"Liu, W. et al. DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance. Pancreas 43, 1264\u20131270 (2014).","journal-title":"Pancreas"},{"key":"708_CR9","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/S0002-9440(10)63008-8","volume":"159","author":"SC Abraham","year":"2001","unstructured":"Abraham, S. C. et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC\/beta-catenin pathway and chromosome 11p. Am. J. Pathol. 159, 1619\u20131627 (2001).","journal-title":"Am. J. Pathol."},{"key":"708_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1158\/0008-5472.CAN-17-2581","volume":"78","author":"T Isobe","year":"2018","unstructured":"Isobe, T. et al. Integrated molecular characterization of the lethal pediatric cancer pancreatoblastoma. Cancer Res. 78, 865\u2013876 (2018).","journal-title":"Cancer Res."},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"101359","DOI":"10.1016\/j.tranon.2022.101359","volume":"18","author":"T Liu","year":"2022","unstructured":"Liu, T., Zhao, T., Shi, C. & Chen, L. Pancreatoblastoma in children: clinical management and literature review. Transl. Oncol. 18, 101359 (2022).","journal-title":"Transl. Oncol."},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/jjco\/hyad176","volume":"54","author":"K Ikezawa","year":"2024","unstructured":"Ikezawa, K. et al. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment. Jpn. J. Clin. Oncol. 54, 271\u2013281 (2024).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"708_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho, W. J., Jaffee, E. M. & Zheng, L. The tumour microenvironment in pancreatic cancer\u2014clinical challenges and opportunities. Nat. Rev. Clin. Oncol. 17, 527\u2013540 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"708_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-019-1345-6","volume":"14","author":"M Orth","year":"2019","unstructured":"Orth, M. et al. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiat. Oncol. 14, 141 (2019).","journal-title":"Radiat. Oncol."},{"key":"708_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13046-023-02935-3","volume":"43","author":"W Luo","year":"2024","unstructured":"Luo, W., Wen, T. & Qu, X. Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept. J. Exp. Clin. Cancer Res. 43, 8 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"708_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu, J., Lamouille, S. & Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156\u2013172 (2009).","journal-title":"Cell Res."},{"key":"708_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20474-9","volume":"12","author":"N Noureen","year":"2021","unstructured":"Noureen, N. et al. Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation. Nat. Commun. 12, 139 (2021).","journal-title":"Nat. Commun."},{"key":"708_CR18","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell 171, 1437\u20131452.e1417 (2017).","journal-title":"Cell"},{"key":"708_CR19","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1128\/MCB.00413-08","volume":"28","author":"C Haumaitre","year":"2008","unstructured":"Haumaitre, C., Lenoir, O. & Scharfmann, R. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Mol. Cell Biol. 28, 6373\u20136383 (2008).","journal-title":"Mol. Cell Biol."},{"key":"708_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/sj.onc.1208272","volume":"24","author":"N Takai","year":"2005","unstructured":"Takai, N., Hamanaka, R., Yoshimatsu, J. & Miyakawa, I. Polo-like kinases (Plks) and cancer. Oncogene 24, 287\u2013291 (2005).","journal-title":"Oncogene"},{"key":"708_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tranon.2016.10.003","volume":"10","author":"Z Liu","year":"2017","unstructured":"Liu, Z., Sun, Q. & Wang, X. PLK1, a potential target for cancer therapy. Transl. Oncol. 10, 22\u201332 (2017).","journal-title":"Transl. Oncol."},{"key":"708_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/cncy.22597","volume":"130","author":"Q Wang","year":"2022","unstructured":"Wang, Q. & Reid, M. D. Cytopathology of solid pancreatic neoplasms: an algorithmic approach to diagnosis. Cancer Cytopathol. 130, 491\u2013510 (2022).","journal-title":"Cancer Cytopathol."},{"key":"708_CR23","doi-asserted-by":"crossref","unstructured":"Masugi, Y. The desmoplastic stroma of pancreatic cancer: multilayered levels of heterogeneity, clinical significance, and therapeutic opportunities. Cancers 14, 3293 (2022).","DOI":"10.3390\/cancers14133293"},{"key":"708_CR24","doi-asserted-by":"crossref","unstructured":"Song, Y., Wang, L., Wang, K., Lu, Y. & Zhou, P. COL12A1 acts as a novel prognosis biomarker and activates cancer-associated fibroblasts in pancreatic cancer through bioinformatics and experimental validation. Cancers 15, 1480 (2023).","DOI":"10.3390\/cancers15051480"},{"key":"708_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s12105-023-01578-2","volume":"17","author":"MG Romanish","year":"2023","unstructured":"Romanish, M. G. & Seethala, R. R. True oncocytic acinic cell carcinoma: a case image. Head. Neck Pathol. 17, 883\u2013885 (2023).","journal-title":"Head. Neck Pathol."},{"key":"708_CR26","first-page":"221","volume":"20","author":"O Lompo","year":"2000","unstructured":"Lompo, O. et al. [Solid and pseudopapillary tumor of the pancreas: immunohistochemical and ultrastructural study of 2 pediatric cases]. Ann. Pathol. 20, 221\u2013224 (2000).","journal-title":"Ann. Pathol."},{"key":"708_CR27","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/jmedgenet-2012-101159","volume":"49","author":"E Fassone","year":"2012","unstructured":"Fassone, E. & Rahman, S. Complex I deficiency: clinical features, biochemistry and molecular genetics. J. Med. Genet. 49, 578\u2013590 (2012).","journal-title":"J. Med. Genet."},{"key":"708_CR28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ajhg.2009.04.020","volume":"84","author":"A Saada","year":"2009","unstructured":"Saada, A. et al. Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. Am. J. Hum. Genet. 84, 718\u2013727 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"708_CR29","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1073\/pnas.85.13.4934","volume":"85","author":"AW Bach","year":"1988","unstructured":"Bach, A. W. et al. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl Acad. Sci. USA 85, 4934\u20134938 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"708_CR30","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1073\/pnas.68.12.2982","volume":"68","author":"P Van der Werf","year":"1971","unstructured":"Van der Werf, P., Orlowski, M. & Meister, A. Enzymatic conversion of 5-oxo-L-proline (L-pyrrolidone carboxylate) to L-glutamate coupled with cleavage of adenosine triphosphate to adenosine diphosphate, a reaction in the -glutamyl cycle. Proc. Natl Acad. Sci. USA 68, 2982\u20132985 (1971).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"708_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1006\/geno.1994.1013","volume":"19","author":"G Hoefler","year":"1994","unstructured":"Hoefler, G. et al. cDNA cloning of the human peroxisomal enoyl-CoA hydratase: 3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme and localization to chromosome 3q26.3-3q28: a free left Alu Arm is inserted in the 3\u2019 noncoding region. Genomics 19, 60\u201367 (1994).","journal-title":"Genomics"},{"key":"708_CR32","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/B978-0-444-59565-2.00044-7","volume":"113","author":"J Jaeken","year":"2013","unstructured":"Jaeken, J. Congenital disorders of glycosylation. Handb. Clin. Neurol. 113, 1737\u20131743 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"708_CR33","doi-asserted-by":"crossref","unstructured":"Kim, A. Y. et al. Pitfalls in the diagnosis of hereditary fructose intolerance. Pediatrics 146, e20193324 (2020).","DOI":"10.1542\/peds.2019-3324"},{"key":"708_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ajhg.2014.12.013","volume":"96","author":"SB Wortmann","year":"2015","unstructured":"Wortmann, S. B. et al. CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. Am. J. Hum. Genet. 96, 245\u2013257 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"708_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/jmedgenet-2014-102914","volume":"52","author":"E Ostergaard","year":"2015","unstructured":"Ostergaard, E. et al. Mutations in COA3 cause isolated complex IV deficiency associated with neuropathy, exercise intolerance, obesity, and short stature. J. Med. Genet. 52, 203\u2013207 (2015).","journal-title":"J. Med. Genet."},{"key":"708_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02747-z","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard, S. et al. A review on the role of cyclin dependent kinases in cancers. Cancer Cell Int. 22, 325 (2022).","journal-title":"Cancer Cell Int."},{"key":"708_CR37","doi-asserted-by":"publisher","first-page":"19592","DOI":"10.1074\/jbc.M314208200","volume":"279","author":"CS Park","year":"2004","unstructured":"Park, C. S. et al. Modulation of beta-catenin phosphorylation\/degradation by cyclin-dependent kinase 2. J. Biol. Chem. 279, 19592\u201319599 (2004).","journal-title":"J. Biol. Chem."},{"key":"708_CR38","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1158\/0008-5472.CAN-12-3947","volume":"73","author":"Z Li","year":"2013","unstructured":"Li, Z. et al. Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway. Cancer Res. 73, 3041\u20133050 (2013).","journal-title":"Cancer Res."},{"key":"708_CR39","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.3748\/wjg.v11.i19.2906","volume":"11","author":"L Zhang","year":"2005","unstructured":"Zhang, L. et al. Nestin-positive progenitor cells isolated from human fetal pancreas have phenotypic markers identical to mesenchymal stem cells. World J. Gastroenterol. 11, 2906\u20132911 (2005).","journal-title":"World J. Gastroenterol."},{"key":"708_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1440-1827.2007.02143.x","volume":"57","author":"N Ohike","year":"2007","unstructured":"Ohike, N. et al. Immunohistochemical analysis of nestin and c-kit and their significance in pancreatic tumors. Pathol. Int. 57, 589\u2013593 (2007).","journal-title":"Pathol. Int."},{"key":"708_CR41","doi-asserted-by":"publisher","first-page":"e29112","DOI":"10.1002\/pbc.29112","volume":"68","author":"E Bien","year":"2021","unstructured":"Bien, E. et al. Pancreatoblastoma in children: EXPeRT\/PARTNER diagnostic and therapeutic recommendations. Pediatr. Blood Cancer 68, e29112 (2021).","journal-title":"Pediatr. Blood Cancer"},{"key":"708_CR42","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1021\/acs.jproteome.9b00686","volume":"19","author":"DM Marchione","year":"2020","unstructured":"Marchione, D. M. et al. HYPERsol: high-quality data from archival FFPE tissue for clinical proteomics. J. Proteome Res. 19, 973\u2013983 (2020).","journal-title":"J. Proteome Res."},{"key":"708_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79049-9","volume":"10","author":"A Tanaka","year":"2020","unstructured":"Tanaka, A. et al. DEAD-box RNA helicase protein DDX21 as a prognosis marker for early stage colorectal cancer with microsatellite instability. Sci. Rep. 10, 22085 (2020).","journal-title":"Sci. Rep."},{"key":"708_CR44","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3389\/fonc.2020.00945","volume":"10","author":"A Tanaka","year":"2020","unstructured":"Tanaka, A. et al. Maspin as a prognostic marker for early stage colorectal cancer with microsatellite instability. Front. Oncol. 10, 945 (2020).","journal-title":"Front. Oncol."},{"key":"708_CR45","doi-asserted-by":"publisher","first-page":"e0229252","DOI":"10.1371\/journal.pone.0229252","volume":"15","author":"A Tanaka","year":"2020","unstructured":"Tanaka, A. et al. STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability. PLoS ONE 15, e0229252 (2020).","journal-title":"PLoS ONE"},{"key":"708_CR46","doi-asserted-by":"publisher","first-page":"813","DOI":"10.18632\/oncotarget.27491","volume":"11","author":"A Tanaka","year":"2020","unstructured":"Tanaka, A. et al. Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer. Oncotarget 11, 813\u2013824 (2020).","journal-title":"Oncotarget"},{"key":"708_CR47","doi-asserted-by":"publisher","first-page":"113810","DOI":"10.1016\/j.celrep.2024.113810","volume":"43","author":"A Tanaka","year":"2024","unstructured":"Tanaka, A. et al. Proteogenomic characterization of primary colorectal cancer and metastatic progression identifies proteome-based subtypes and signatures. Cell Rep. 43, 113810 (2024).","journal-title":"Cell Rep."},{"key":"708_CR48","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","volume":"179","author":"DJ Clark","year":"2019","unstructured":"Clark, D. J. et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell 179, 964\u2013983.e931 (2019).","journal-title":"Cell"},{"key":"708_CR49","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","volume":"179","author":"Q Gao","year":"2019","unstructured":"Gao, Q. et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell 179, 561\u2013577.e522 (2019).","journal-title":"Cell"},{"key":"708_CR50","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","volume":"177","author":"S Vasaikar","year":"2019","unstructured":"Vasaikar, S. et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 177, 1035\u20131049.e1019 (2019).","journal-title":"Cell"},{"key":"708_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.06.012","volume":"182","author":"YJ Chen","year":"2020","unstructured":"Chen, Y. J. et al. Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression. Cell 182, 226\u2013244.e217 (2020).","journal-title":"Cell"},{"key":"708_CR52","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette, M. A. et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200\u2013225.e235 (2020).","journal-title":"Cell"},{"key":"708_CR53","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.cell.2020.10.036","volume":"183","author":"K Krug","year":"2020","unstructured":"Krug, K. et al. Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy. Cell 183, 1436\u20131456.e1431 (2020).","journal-title":"Cell"},{"key":"708_CR54","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/j.cell.2021.07.016","volume":"184","author":"S Satpathy","year":"2021","unstructured":"Satpathy, S. et al. A proteogenomic portrait of lung squamous cell carcinoma. Cell 184, 4348\u20134371.e4340 (2021).","journal-title":"Cell"},{"key":"708_CR55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng, D. T. et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J. Mol. Diagn. 17, 251\u2013264 (2015).","journal-title":"J. Mol. Diagn."},{"key":"708_CR56","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."},{"key":"708_CR57","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794\u20131805 (2011).","journal-title":"J. Proteome Res."},{"key":"708_CR58","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell Proteom. 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"708_CR59","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116\u20135121 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"708_CR60","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"708_CR61","unstructured":"Storey, J. D., Bass, A. J., Dabney, A. & Robinson, D. qvalue: Q-value estimation for false discovery rate control. GitHub http:\/\/github.com\/jdstorey\/qvalue (2024)."},{"key":"708_CR62","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"708_CR63","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"708_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12863-018-0617-8","volume":"19","author":"DM Braun","year":"2018","unstructured":"Braun, D. M., Chung, I., Kepper, N., Deeg, K. I. & Rippe, K. TelNet\u2014a database for human and yeast genes involved in telomere maintenance. BMC Genet. 19, 32 (2018).","journal-title":"BMC Genet."},{"key":"708_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-024-00708-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-024-00708-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-024-00708-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T05:07:02Z","timestamp":1727932022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-024-00708-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1038\/s41698-024-00708-5","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.T., J.Y.W., Y.Z., M.O., and R.C.H. declare no conflicts of interest related to this study. D.S.K. is a consultant for and equity holder in Paige.AI and a consultant for Merck. M.H.R. is a member of the Scientific Advisory Board of Universal Diagnostics (UDX). None of these companies had any role in the support, design, execution, data analysis, or any other aspect of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}